Close

Analyst Ratings for Ultragenyx Pharma (RARE) [Buys]

All Latest Ratings for RARE

RARE Rating Summary

RARE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RARE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $86.47 (+121.3%) * Over Last 12-Mos
Rating Score: 7.3 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/18/2023 Canaccord Genuity Whitney Ijem New Coverage Buy
(N/A)		 N/A
(N/A)		 42.50
(39.07)		 -8.07% Details
12/30/2022 H.C. Wainwright Ed Arce New Coverage Buy
(N/A)		 82.00
(N/A)		 45.17
(39.07)		 -13.5% Details
Like RARE Ratings? Also take a look at ABEO, MREO, NTLA, IMRX

RARE Ratings News